Dystroglycan anticorps (C-Term)

N° du produit ABIN928109

Détail du produit anti-Dystroglycan anticorps

Antigène: Dystroglycan (DAG1) (Dystroglycan 1 (DAG1))

Épitope: C-Term

Reactivité: Humain, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Dystroglycan est non-conjugé

Application: Western Blotting (WB)

Réactivité croisée: Souris

Purification: Purified

Immunogène: Dag1 antibody was raised in rabbit using the C terminal of Dag1 as the immunogen

Information d'application

Indications d'application: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Commentaires:

Dag1 Blocking Peptide, catalog no. 33R-7277, is also available for use as a blocking control in assays to test for specificity of this Dag1 antibody

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Concentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Détails sur Dystroglycan

Antigène: Dystroglycan (DAG1) (Dystroglycan 1 (DAG1))

Autre désignation: Dag1 (DAG1 Produits)

Synonymes: anticorps LOC398500, anticorps dag1, anticorps MGC53537, anticorps 156DAG, anticorps A3a, anticorps AGRNR, anticorps DAG, anticorps MDDGC7, anticorps MDDGC9, anticorps DAG1, anticorps RAB7, anticorps dg, anticorps a3a, anticorps dag, anticorps agrnr, anticorps 156dag, anticorps D9Wsu13e, anticorps DG, anticorps Dp427, anticorps Dp71, anticorps CG18250, anticorps CT41273, anticorps DmDG, anticorps Dmel\\CG18250, anticorps atu, anticorps dgn, anticorps dys, anticorps GB14967, anticorps APOJ, anticorps CLI, anticorps RATTRPM2B, anticorps SGP-2, anticorps SGP2, anticorps SP-40, anticorps SP40, anticorps TRPM-2, anticorps TRPM2B, anticorps Trpm2, anticorps Trpmb, anticorps Ala-1, anticorps H9/25, anticorps Ly-27, anticorps Ly-6, anticorps Ly27, anticorps wu:fb83d06, anticorps wu:fi25f06, anticorps wu:fi37b08, anticorps zgc:109786, anticorps DystroGlycaN, anticorps dystroglycan 1 L homeolog, anticorps dystroglycan 1, anticorps dystroglycan 1 S homeolog, anticorps Dystroglycan, anticorps dystroglycan, anticorps clusterin, anticorps lymphocyte antigen 6 complex, anticorps dgn-1, anticorps dag1.L, anticorps dgn-2, anticorps dgn-3, anticorps DAG1, anticorps dag1.S, anticorps Dag1, anticorps dag1, anticorps Dg, anticorps LOC408826, anticorps Clu, anticorps Ly6

Sujet: The dystroglycan complex is involved in a number of processes including laminin and basement membrane assembly, sacrolemmal stability, cell survival, peripheral nerve myelination, nodal structure, cell migration, and epithelial polarization.Alpha-dystroglycan is an extracellular peripheral glycoprotein that acts as a receptor for both extracellular matrix proteins containing laminin-G domains, and for certain adenoviruses. Receptor for laminin-2 (LAMA2) and agrin in peripheral nerve Schwann cells. Synonyms: Polyclonal Dag1 antibody, Anti-Dag1 antibody, dystroglycan 1 antibody, D9Wsu13e antibody, DG antibody, Dp427 antibody, Dp71 antibody.

Pathways: Maintenance of Protein Location, Regulation of Carbohydrate Metabolic Process, Protein targeting to Nucleus